Cargando…
Future Directions in Maintenance Therapy in Multiple Myeloma
Autologous stem cell transplantation (ASCT) has been a backbone of therapy for newly diagnosed patients with multiple myeloma eligible for high-dose therapy for decades. Survival outcomes have continued to improve over time, in part because of the incorporation of highly effective induction regimens...
Autores principales: | Holstein, Sarah A., Suman, Vera J., Hillengass, Jens, McCarthy, Philip L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197068/ https://www.ncbi.nlm.nih.gov/pubmed/34073689 http://dx.doi.org/10.3390/jcm10112261 |
Ejemplares similares
-
Physical Activity in Multiple Myeloma: A Review of the Current Literature
por: Hillengass, Michaela, et al.
Publicado: (2023) -
Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma
por: Dimopoulos, Meletios A., et al.
Publicado: (2020) -
Gaps and opportunities in the treatment of relapsed-refractory multiple myeloma: Consensus recommendations of the NCI Multiple Myeloma Steering Committee
por: Kumar, Shaji, et al.
Publicado: (2022) -
The role of maintenance therapy in multiple myeloma
por: Lipe, B, et al.
Publicado: (2016) -
Targeting the Isoprenoid Biosynthetic Pathway in Multiple Myeloma
por: Haney, Staci L., et al.
Publicado: (2022)